Table 5.

Summary of infections

Variable	No. of episodes	No. of patients with ≥1 episode/no. at risk	%	Median days to infection (range)
Any infection type*	143	65/96	68	48 (1-180)
Viral*	28	26/96	27	71.5 (1-172)
Fungal	19	17/96	18	66 (3-180)
Bacterial	96	57/96	59	44.5 (1-180)
CMV viremia†	27	27/53‡	51	41 (9-131)
Hemorrhagic cystitis	19	19/96	20	24 (4-141)

^*Does not include CMV or urine BK/adenovirus.

^†CMV viremia defined as >150 copies/mL on PCR.

^‡CMV at-risk defined as donor CMV-positive, recipient CMV-positive, or both donor and recipient positive during pre-BMT evaluation, and includes 1 patient who was neither donor nor recipient positive but had CMV viremia.